Long life expectancy can be attributed to healthy eating, research suggests. As a general rule, a healthy, balanced diet should consist of at least five portions of a variety of fruit and vegetables every day. It is also highly recommended to get enough exercise and the recommended amount is at least 150 minutes per week. With wintry days, so comes the need for a warm brew to warm us up from the inside and according to studies, drinking this warm beverage could help boost your longevity too.
While men can take solace in a new government report that shows prostate cancer cases have been declining overall in the past two decades, the same analysis finds that the opposite is true for advanced prostate cancer cases.
A type of smart MRI scan used in people with heart disease could help assess whether children's cancers are especially aggressive and spot early signs that targeted treatments are working, a new study suggested.
In a first-time disclosure of IPN60090, a small-molecule inhibitor of the metabolic enzyme glutaminase (GLS1), researchers from The University of Texas MD Anderson Cancer Center's Therapeutics Discovery division and Ipsen Biopharmaceuticals reported the preclinical discovery and early-stage clinical development of this novel drug. IPN60090, now under investigation in a Phase I trial, may hold benefit for certain patients with lung and ovarian cancers.
A genetic mutation that disrupts how DNA sends messages to the rest of a cell has been linked to a large number of blood cancers. Thanks to a collaboration between biologists at Cold Spring Harbor Laboratory (CSHL) and an oncologist at Memorial Sloan Kettering Cancer Center (MSKCC), we now know how the mutation triggers a chain of biological events that lead to most leukemia’s.
A consortium of researchers led by investigators from Georgetown Lombardi Comprehensive Cancer Center, Washington, DC, the US, have completed the largest analysis of a new gene fusion they believe is responsible for development of a wide spectrum of cancer types.
Researchers at the George Washington University (GW) Cancer Center found that the enzyme USP15 could potentially lead to new treatments for breast and pancreatic cancer. Their findings were published in Nature Communications.